VP (Research and International Relations) news
A new study published in the journal Arthritis Care & Research, led by Dr. Mary-Ann Fitzcharles, a rheumatologist at the McGill University Health Centre, reveals that 13 per cent of FM patients use cannabinoids for relief from symptoms such as widespread pain, fatigue, and insomnia.
McGill University scientists, led by Ajjamada Kushalappa of the Faculty of Agricultural and Environmental Sciences, have teamed up with researchers from the Universidad Nacional de Colombia to develop nutritious, high-yielding, and more disease-resistant potatoes for food-insecure indigenous communities in Colombia.
Mauro Dell’Ambrogio, Swiss Secretary of State for Education and Research, and Ulrich Lehner, Ambassador of Switzerland to Canada and the Bahamas, recently paid a high-profile visit to McGill University. One of their primary goals was to show support for and learn more about the innovative partnership that exists between the Brain@McGill and the Neuroscience Center Zurich.
Report by blue-ribbon panel, including McGill Principal Munroe-Blum, highlights links between world-class research universities and future prosperity
Cachexia, a syndrome characterized by rapid weight loss and muscle deterioration, is a major cause of death among patients suffering from diseases like cancer, AIDS and chronic infection. Now, a newly published study by McGill University researchers shows that a low dose of Pateamine A is effective at preventing cancer-induced muscle wasting, which may lead to cachexia-fighting drugs.
Two McGill researchers were recently awarded large partnership grants by the Social Sciences and Humanities Research Council (SSHRC). These grants are designed to foster research partnerships among the academic, private, public and not-for-profit sectors.
Whether it is for research into clean energy sources, the future of wireless communication or a better understanding of the processes involved in language learning, over 160 established McGill researchers and more than 80 graduate students will benefit from support from the Natural Sciences and Engineering Research Council of Canada (NSERC) over the next five years.
Message from the Office of Sponsored Research and Research Financial Management Services to the McGill Research Community
This communiqué updates the McGill community of some important changes that the Office of Sponsored Research and Research Financial Management Services are undertaking in order to improve our collective services for researchers.
Raptor Pharmaceutical recently announced that it has acquired exclusive rights to intellectual property related to cysteamine and related compounds in the potential treatment of parasitic diseases, including malaria, from McGill.
BioFuelNet Canada – made possible by federal NCE program – will bring together industry and academics to research and develop biofuels of the future
McGill and AMURE met on May 16 and signed off on the final English and French versions of seven articles in the Research Associates and Research Assistants collective agreements.